• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫腺肌病与不孕:体外受精及手术后生殖结局的综述

Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery.

作者信息

Dueholm Margit

机构信息

Department of Gynecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Acta Obstet Gynecol Scand. 2017 Jun;96(6):715-726. doi: 10.1111/aogs.13158.

DOI:10.1111/aogs.13158
PMID:28556124
Abstract

This review includes an analysis of the clinical studies evaluating reproductive outcome and adenomyosis, and a review of studies on reproductive outcome and surgical treatment options for adenomyosis. Strict diagnostic criteria and classification of disease are needed for an image diagnosis of adenomyosis. Studies of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) populations and women with surgically treated deep endometriosis have suggested that adenomyosis has a negative impact on reproductive outcome, although there are substantial variations between studies. Few data are available on the relation between the extent of disease and impact on reproductive outcome, but a correlation appears to exist. Case series seem to confirm a positive effect of gonadotropin-releasing hormone analog treatment and surgery on reproductive outcome, but there are no controlled trials. Evidence is impaired by the poor quality of many studies, a lack of strict image diagnosis, and the absence of a classification of the extent of disease. Selection of the optimal evidence-based treatment options for adenomyosis in the fertility clinic is difficult because of a lack of evidence regarding the relation between fertility and the degree and composition of adenomyosis. Adenomyosis may reduce implantation so severely that surgical or other treatment options should be recommended, but the benefit of these treatment options needs to be verified. Referral of women with adenomyosis and recurrent miscarriage and repeated failure of assisted reproductive technology to centers with a special interest in adenomyosis research and treatment may be critical.

摘要

本综述包括对评估子宫腺肌病生殖结局的临床研究的分析,以及对子宫腺肌病生殖结局和手术治疗选择的研究综述。子宫腺肌病的影像学诊断需要严格的诊断标准和疾病分类。对体外受精/卵胞浆内单精子注射(IVF/ICSI)人群以及接受手术治疗的深部子宫内膜异位症女性的研究表明,子宫腺肌病对生殖结局有负面影响,尽管不同研究之间存在很大差异。关于疾病程度与对生殖结局影响之间的关系,可用数据很少,但似乎存在相关性。病例系列似乎证实了促性腺激素释放激素类似物治疗和手术对生殖结局有积极作用,但尚无对照试验。许多研究质量较差、缺乏严格的影像学诊断以及疾病程度分类缺失,影响了证据的可靠性。由于缺乏关于生育能力与子宫腺肌病程度及组成之间关系的证据,在生育门诊选择基于证据的子宫腺肌病最佳治疗方案很困难。子宫腺肌病可能严重降低着床率,因此应推荐手术或其他治疗方案,但这些治疗方案的益处需要得到验证。将患有子宫腺肌病、复发性流产和辅助生殖技术反复失败的女性转诊至对子宫腺肌病研究和治疗有特殊兴趣的中心可能至关重要。

相似文献

1
Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery.子宫腺肌病与不孕:体外受精及手术后生殖结局的综述
Acta Obstet Gynecol Scand. 2017 Jun;96(6):715-726. doi: 10.1111/aogs.13158.
2
The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis.子宫腺肌病对体外受精结局的影响:一项系统评价和荟萃分析。
Reprod Sci. 2022 Nov;29(11):3177-3193. doi: 10.1007/s43032-021-00818-6. Epub 2022 Jan 3.
3
Adenomyosis reduces pregnancy rates in infertile women undergoing IVF.子宫腺肌病降低了接受试管婴儿治疗的不孕女性的妊娠率。
Reprod Biomed Online. 2012 Sep;25(3):273-7. doi: 10.1016/j.rbmo.2012.05.003. Epub 2012 May 23.
4
The Impact of Adenomyosis on Women's Fertility.子宫腺肌病对女性生育能力的影响。
Obstet Gynecol Surv. 2016 Sep;71(9):557-68. doi: 10.1097/OGX.0000000000000346.
5
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].国产高纯度尿促卵泡素对控制性卵巢刺激中体外受精-胚胎移植结局的影响
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42.
6
Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients.腺肌病是否会影响 IVF 周期的妊娠结局?973 例患者的回顾性分析。
Reprod Biomed Online. 2019 Jan;38(1):13-21. doi: 10.1016/j.rbmo.2018.09.014. Epub 2018 Oct 26.
7
Proposed classification of adenomyosis in Infertile women to simplify management options undergoing ART.建议对不孕妇女的腺肌病进行分类,以简化接受 ART 的管理选择。
JBRA Assist Reprod. 2024 Jun 1;28(2):353-357. doi: 10.5935/1518-0557.20240015.
8
Fertility-Sparing Treatment of Adenomyosis in Patients With Infertility: A Systematic Review of Current Options.不孕症患者子宫腺肌病的保留生育功能治疗:当前选择的系统评价
Reprod Sci. 2018 Apr;25(4):480-486. doi: 10.1177/1933719118756754. Epub 2018 Feb 5.
9
Treatment options and reproductive outcome for adenomyosis-associated infertility.子宫腺肌病相关性不孕的治疗选择及生殖结局
Curr Med Res Opin. 2018 May;34(5):839-849. doi: 10.1080/03007995.2017.1393404. Epub 2017 Nov 10.
10
Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging.常规 IVF 作为一种实验室策略,用于挽救严重低反应患者的生育潜能:生殖衰老的影响。
Gynecol Endocrinol. 2013 Nov;29(11):997-1001. doi: 10.3109/09513590.2013.822063. Epub 2013 Aug 2.

引用本文的文献

1
Scientific landscape and visualization analysis of the link between adenomyosis and infertility from 2000 to 2024.2000年至2024年子宫腺肌病与不孕症之间联系的科学态势与可视化分析
Front Med (Lausanne). 2025 Feb 19;12:1488866. doi: 10.3389/fmed.2025.1488866. eCollection 2025.
2
Medical treatment before in-vitro fertilization in patients with adenomyosis: a systematic review and meta-analysis.子宫腺肌病患者体外受精前的医学治疗:系统评价与荟萃分析。
J Assist Reprod Genet. 2025 Feb;42(2):381-388. doi: 10.1007/s10815-024-03323-2. Epub 2024 Dec 12.
3
Reproductive surgery remains an essential element of reproductive medicine.
生殖外科手术仍然是生殖医学的一个重要组成部分。
Facts Views Vis Obgyn. 2024 Jun;16(2):145-162. doi: 10.52054/FVVO.16.2.022.
4
Current Medical Therapy for Adenomyosis: From Bench to Bedside.腺肌病的当前医学治疗:从基础到临床。
Drugs. 2023 Nov;83(17):1595-1611. doi: 10.1007/s40265-023-01957-7. Epub 2023 Oct 14.
5
Fertility and Obstetric Outcomes of Assisted Reproductive Technology (ART) in Women With Adenomyosis Following Gonadotropin-Releasing Hormone Agonist Therapy: A Single-Center Experience.促性腺激素释放激素激动剂治疗后子宫腺肌病患者辅助生殖技术(ART)的生育力及产科结局:单中心经验
Cureus. 2023 Sep 4;15(9):e44691. doi: 10.7759/cureus.44691. eCollection 2023 Sep.
6
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis.亚洲子宫内膜异位症和子宫腺肌病学会子宫腺肌病管理指南
Reprod Med Biol. 2023 Sep 10;22(1):e12535. doi: 10.1002/rmb2.12535. eCollection 2023 Jan-Dec.
7
MIR503HG silencing promotes endometrial stromal cell progression and metastasis and suppresses apoptosis in adenomyosis by activating the Wnt/β‑catenin pathway via targeting miR‑191.MIR503HG沉默通过靶向miR-191激活Wnt/β-连环蛋白通路,促进子宫腺肌病中子宫内膜间质细胞的进展和转移并抑制其凋亡。
Exp Ther Med. 2023 Jan 30;25(3):117. doi: 10.3892/etm.2023.11816. eCollection 2023 Mar.
8
Impact of Adenomyosis on Infertile Patients-Therapy Options and Reproductive Outcomes.子宫腺肌病对不孕患者的影响——治疗选择与生殖结局
Biomedicines. 2022 Dec 13;10(12):3245. doi: 10.3390/biomedicines10123245.
9
Implantation Failure in Endometriosis Patients: Etiopathogenesis.子宫内膜异位症患者的种植失败:病因发病机制。
J Clin Med. 2022 Sep 13;11(18):5366. doi: 10.3390/jcm11185366.
10
Reproductive Outcomes of Fertilization and Fresh Embryo Transfer in Infertile Women With Adenomyosis: A Retrospective Cohort Study.腺肌病不孕妇女行体外受精-新鲜胚胎移植的妊娠结局:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Jul 29;13:865358. doi: 10.3389/fendo.2022.865358. eCollection 2022.